Last reviewed · How we verify
NCT05499247
A Proof-of-Concept, Safety and Efficacy Study of SkinQ Glow Bright Wonder Mask in Healthy Human Subjects
NA trial testing SkinQ Glow Bright Wonder Mask in Healthy Human Volunteers With Visibly Tanned Skin in 38 participants. Completed in 14 September 2022.
6 September 2022
Quick facts
| Lead sponsor | NovoBliss Research Pvt Ltd |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 38 |
| Start date | 29 August 2022 |
| Primary completion | 6 September 2022 |
| Estimated completion | 14 September 2022 |
| Sites | 1 location across India |
Drugs / interventions tested
- SkinQ Glow Bright Wonder Mask
Conditions studied
- Healthy Human Volunteers With Visibly Tanned Skin — all drugs for Healthy Human Volunteers With Visibly Tanned Skin →
Sponsor
NovoBliss Research Pvt Ltd — full company profile →
Who can join
Adults 18 to 55, any sex, with Healthy Human Volunteers With Visibly Tanned Skin. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an open-label, single-arm, single-centre, proof-of-concept, safety and efficacy, clinical study of SkinQ Glow Bright Wonder Mask in Healthy Human Subjects and adequate representation of varied skin types \[Normal, Oily, Dry, Combined and Sensitive skin\]. The rationale of the study is to evaluate whether the product SkinQ Glow Bright Wonder Mask is providing an instant skin tanning reduction in 15 mins, smoother, softer and glows skin, and even/brighter complexion in 15 mins, instant improvement in skin brightness and not just a marketing gimmick. It is also to assess the efficacy of the product in its performance for the following parameters: * Tan reduction * Close pores * Makes skin bright and radiant. * Removes tan marks * Fades dark spots of pimple and acne * Gives a glowing look * The texture of the product, experience, acceptability
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05499247
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other NovoBliss Research Pvt Ltd trials
Trials by the same sponsor.
- NCT07466667 — To Determine the Effect of Phaseolean on Glycemic Response to Carbohydrate Rich Meal in Healthy Adult Human Participants · NA · not yet recruiting
- NCT07423325 — Validation of Skin Instrumentation to Detect Ceramide-Driven Lipid Replenishment - Assessing Skin Glow, Hydration, Trans · NA · not yet recruiting
- NCT07333300 — Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Der · NA · not yet recruiting
- NCT07324759 — Clinical Study to Assess Safety, Effectiveness and In-Use Tolerability of Saffron Extract Capsules for Improving Skin He · NA · not yet recruiting
- NCT07195487 — A Clinical Study to Evaluate the Safety, Effectiveness and In-Use Tolerability of Hair Growth and Scalp Health Serum in · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05499247 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NovoBliss Research Pvt Ltd
- Last refreshed: 29 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05499247.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing